NCT07312916 (MADRID) is a NA clinical trial of Hand-massage in Chronic Kidney Disease Associated Pruritus, sponsored by University of Applied Sciences of Western Switzerland.

Who is sponsoring NCT07312916?

NCT07312916 is sponsored by University of Applied Sciences of Western Switzerland.

What drugs are being tested in NCT07312916?

Interventions in NCT07312916: Hand-massage.

What condition does NCT07312916 study?

NCT07312916 studies Chronic Kidney Disease Associated Pruritus.

Is NCT07312916 still recruiting?

NCT07312916 is currently recruiting now. Last updated 16 March 2026.

Last reviewed 2026-03-16 · How we verify

NCT07312916: MADRID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Hand Massage on Chronic Kidney Disease Associated Pruritus in Patients Receiving Hemodialysis

Recruiting now NA Last updated 16 March 2026

What this trial tests

NA trial testing Hand-massage in Chronic Kidney Disease Associated Pruritus in 54 participants. Currently enrolling.

Timeline

17 December 2025

Primary endpoint
30 November 2026

30 June 2027

Quick facts

Lead sponsor	University of Applied Sciences of Western Switzerland
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	54
Start date	17 December 2025
Primary completion	30 November 2026
Estimated completion	30 June 2027
Sites	4 locations across Switzerland

Drugs / interventions tested

Hand-massage

Conditions studied

Chronic Kidney Disease Associated Pruritus — all drugs for Chronic Kidney Disease Associated Pruritus →

Sponsor

University of Applied Sciences of Western Switzerland

Who can join

18 and older, any sex, with Chronic Kidney Disease Associated Pruritus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic Kidney Disease-Associated Pruritus (CKD-aP) affects about 25% of Swiss hemodialysis patients, most with moderate to severe itching. It negatively impacts sleep, quality of life, and survival. This mixed-methods study will investigate the effect hand massage delivered by nurses on the itch severity, health-related quality of life and sleep compared to usual care in patients on hemodialysis. Fifty-four patients will be randomized to receive either hand massage or verbal attention over three months. Quantitative data (NRS, 5D Itch Scale, KDQOL-SFv1.2) will be collected at baseline, one, and three months. Qualitative interviews with 12 participants who received the hand massage intervention, will explore their experiences. The intervention is safe, non-invasive, and may offer valuable insights into CKD-aP management and pathogenesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Applied Sciences of Western Switzerland trials

Trials by the same sponsor.

NCT05415969 — CKD-aP Among Adults on Dialysis in Switzerland · completed
NCT04518683 — Rehabilitation With Mobile Applications in Women With SUI · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07312916 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Applied Sciences of Western Switzerland
Last refreshed: 16 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07312916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing